Recombinant TNFRSF4 (Ivuxolimab Biosimilar) antibody

Catalog No. ABIN7675987

The Human Monoclonal anti-TNFRSF4 (Ivuxolimab Biosimilar) antibody is suitable to detect TNFRSF4 (Ivuxolimab Biosimilar) in samples from Human. It has been validated for ELISA, FACS, BLI, Func and SPR.

Quick Overview for Recombinant TNFRSF4 (Ivuxolimab Biosimilar) antibody (ABIN7675987)

Target: TNFRSF4 (Ivuxolimab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This TNFRSF4 (Ivuxolimab Biosimilar) antibody is un-conjugated

Application: ELISA, Flow Cytometry (FACS), Bio-Layer Interferometry (BLI), Functional Studies (Func), Surface Plasmon Resonance (SPR)

Product Details anti-TNFRSF4 (Ivuxolimab Biosimilar) Antibody

Expression System: CHO Cells

Purpose: Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab)

Characteristics: Anti-TNFRSF4 / OX40 / CD134 Reference Antibody (ivuxolimab) is expressed from CHO. The heavy chain type is huIgG2, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.

Purity: >95 %

Isotype: IgG2SA

Application Details

Application Notes: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Handling

Format: Lyophilized

Concentration: 1 mg/mL

Buffer: 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2

Storage: 4 °C,-80 °C

Storage Comment: +4°C,-80°C

Target Details for TNFRSF4 (Ivuxolimab Biosimilar)

Target: TNFRSF4 (Ivuxolimab Biosimilar)

Target Type: Biosimilar

Molecular Weight: 145.5 kDa

UniProt: P43489